|
CTBS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
7.44350000525529E-08 |
| Normal-vs-Stage3 |
1.68459999949633E-07 |
| Normal-vs-Stage4 |
1.758950E-01 |
| Stage1-vs-Stage2 |
1.696420E-01 |
| Stage1-vs-Stage3 |
2.598200E-01 |
| Stage1-vs-Stage4 |
3.477800E-02 |
| Stage2-vs-Stage3 |
8.059400E-01 |
| Stage2-vs-Stage4 |
7.492000E-02 |
| Stage3-vs-Stage4 |
5.986100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.74000830305476E-12 |
| Normal-vs-Asian |
3.571600E-01 |
| Caucasian-vs-AfricanAmerican |
2.704800E-01 |
| Caucasian-vs-Asian |
1.790360E-01 |
| AfricanAmerican-vs-Asian |
2.460200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.00310004746973E-09 |
| Male-vs-Female |
2.077100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.73649983281621E-11 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
3.5198510772716E-12 |
| Normal-vs-Extreme_Obese |
2.11869999988679E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.520050E-01 |
| Normal_Weight-vs-Obese |
9.770800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.482400E-01 |
| Extreme_Weight-vs-Obese |
1.243430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.701800E-01 |
| Obese-vs-Extreme_Obese |
8.641600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.952400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.76996261670138E-15 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.66499958054578E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.963230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.314300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.360500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.325600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.567560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.967200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.5146772724961E-12 |
| Normal-VS-KIRP CIMP |
8.521200E-01 |
| Normal-VS-Unclassified PRCC |
2.29040009180892E-10 |
| Type1 PRCC-VS-Type2 PRCC |
1.207000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.357700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.567900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.341800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.821400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.682000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47613041182149E-12 |
| Normal-vs-N1 |
1.255950E-03 |
| Normal-vs-N2 |
2.763700E-02 |
| N0-vs-N1 |
1.765430E-01 |
| N0-vs-N2 |
2.054400E-01 |
| N1-vs-N2 |
8.068800E-01 |
|
|
